FDA Authorizes COVID Bivalent Shots for Children as Young as Five Years Old
On Oct. 12, 2022, the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) of the COVID bivalent booster versions of messenger RNA (mRNA) Comirnaty and Spikevax biologics developed by Pfizer/BioNTech and Moderna/NIAID for children as young as five or six years old, respectively. The FDA’s decision on Aug. 31 to grant […]
A Critique of The Lancet COVID-19 Commission
Opinion | The Lancet recently released its long-awaited COVID-19 commission report. The report well reflects the current state of public health science and addresses the business needs of The Lancet. It may have been naïve to expect further, but health is an important area and should be taken more seriously. The level of obfuscation of evidence, misrepresentation of […]
FDA Issues New Warning of Cancers Linked to Breast Implants
The U.S. Food and Drug Administration (FDA) issued a safety communication on Sept. 8, 2022 warning that certain cancers may develop in scar tissue “capsules” that form around breast implants. Cancers cited in the report include squamous cell carcinoma and various lymphomas. The malignancies are not exclusive to a certain type of implant and have […]
The Naked Absurdity of Global Public Health
Opinion | Something is fundamentally wrong with global public health. More accurately, something is fundamentally wrong with the mindset of global health professionals, particularly those in positions of leadership. It has become normal to speak, repeat, and defend complete absurdity, as if illusions and fantasies are real. There are no sanctions for operating in this […]
FDA Reports Systemic Health Problems in Women With Breast Implants
Breast implant surgery is the most common cosmetic surgical procedure in the United States, with more than 313,000 surgeries performed in 2018—a 48 percent increase since 2000.1 Silicone implants are the most common reconstructive breast surgery. In 2018, the American Society of Plastic Surgeons (ASPS) reported 101,657 breast reconstruction procedures, of which 78,814 used silicone […]
Paxlovid Users May Face Rebound SARS-CoV-2
The U.S. Centers for Disease Control and Prevention (CDC) has admitted that COVID-19 patients may experience a rebound SARS-CoV-2 infection after taking Pfizer’s antiviral drug, Paxlovid. Evidence has shown that patients, including those who have gotten COVID shots and been boosted, may suffer a reoccurrence of COVID two to eight days after completing a five-day […]
